Andrew N. Schiff

Andrew N. Schiff, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Aclaris Therapeutics, Inc. and Zeltiq Aesthetics Inc. In total, 25 filings cover trades dated from 16 June 2016 to 5 June 2026.

On the open market, the record shows 1 purchase worth €2.1M and 14 sales worth €20.0M. The net balance comes to €17.9M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 7 option exercises.

The newest entry dates from 8 June 2026: an option exercise, in Aclaris Therapeutics, Inc. The latest purchase dates back some time: it was published 3,355 days ago, on 16 August 2017. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.